Market Tracker

12/03 10:49am ET

Pfizer Inc (NYSE:PFE)

53.58
BATS BZX Real-Time Price
As of 10:49am ET
 +0.54 / +1.02%
Today’s Change
33.36
Today|||52-Week Range
55.70
+45.56%
Year-to-Date
2 Stocks That Are Down 60% (or More) From Their 52-Week Highs
10:30am / MotleyFool.com - Paid Partner Content
Moderna (MRNA) Rallies on Booster Hopes Amid Omicron Concerns
Nov 30 / Zacks.com - Paid Partner Content
COVID-19 Vaccine & Drug Makers Gear Up to Fight Omicron
9:20am / Zacks.com - Paid Partner Content
J&J (JNJ) to Explore Omicron Version of its COVID Vaccine
Nov 30 / Zacks.com - Paid Partner Content
7 Stocks That Moved the Most in November
8:15am / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Pfizer, BioNTech, Moderna and Novavax
Nov 30 / Zacks.com - Paid Partner Content
Here's What Vaccine CEOs Have to Say About the Omicron Variant
7:31am / MotleyFool.com - Paid Partner Content
2 Vaccine Stocks to Buy on Concerns About the Omicron Covid Variant
Nov 30 / StockNews.com - Paid Partner Content
Pfizer's Set to Make $131 Billion in COVID Sales in 2 Years. Is the Stock a Buy?
5:55am / MotleyFool.com - Paid Partner Content
Is This Leading COVID Stock a Buy Right Now?
Nov 30 / MotleyFool.com - Paid Partner Content
2 Dirt-Cheap Stocks That Could Skyrocket
2:40am / StockNews.com - Paid Partner Content
Is It Too Late to Buy Viatris Stock?
Nov 30 / MotleyFool.com - Paid Partner Content
3 Stocks to Buy for the New COVID Variant
Dec 02 / MotleyFool.com - Paid Partner Content
Eli Lilly Shares Slide as Price Cuts Batter Its Diabetes Business in China
Nov 29 / GuruFocus News - Paid Partner Content
Pfizer (PFE) Up 22% Since Last Earnings Report: Can It Continue?
Dec 02 / Zacks.com - Paid Partner Content
Omicron Fears Fuel Rally in Vaccine Stocks: Will It Continue?
Nov 29 / Zacks.com - Paid Partner Content
Merck (MRK) Vaxneuvance sBLA for Pediatrics Gets Priority Review
Dec 02 / Zacks.com - Paid Partner Content
Ken Heebner's CGM Mutual Fund 3rd-Quarter Letter
Nov 29 / GuruFocus News - Paid Partner Content
3 Hard Facts Moderna and Pfizer Investors Need to Know About the Omicron Variant
Dec 02 / MotleyFool.com - Paid Partner Content
ETF Areas to Gain/Lose on Fear of Omicron Strain of Coronavirus
Nov 29 / Zacks.com - Paid Partner Content
Ohhh Omicron! From Panic to Possibility
Dec 01 / GuruFocus News - Paid Partner Content
Why Merck Stock Is Slipping Today
Nov 29 / MotleyFool.com - Paid Partner Content
Why Carnival Stock Investors Have No Worries Today
Dec 01 / MotleyFool.com - Paid Partner Content
Deciphera (DCPH) Down More Than 70% in Past 3 Months: Here's Why
Nov 29 / Zacks.com - Paid Partner Content
2 Ridiculously Cheap Dividend Stocks To Buy for 2022
Dec 01 / MotleyFool.com - Paid Partner Content
Cyber Monday to Determine Holiday Sales Fate
Nov 29 / Zacks.com - Paid Partner Content
3 Reasons Pfizer Stock Will Crush the Broader Market in 2022
Dec 01 / MotleyFool.com - Paid Partner Content
Will Cyber Monday Rescue Holiday Shopping from Omicron Fears?
Nov 29 / Zacks.com - Paid Partner Content
Merck (MRK) Up as COVID Pill Gets FDA Panel's Positive Vote
Dec 01 / Zacks.com - Paid Partner Content
So Far, Joe Biden Leads All Presidents in Market Performance
Nov 29 / GuruFocus News - Paid Partner Content
Moderna's (MRNA) Stock Falls on Omicron Variant Concerns
Dec 01 / Zacks.com - Paid Partner Content
Why Moderna Stock Is Spiking Today
Nov 29 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Mastercard, Pfizer, Nike, Lockheed Martin and Micron Tech
Dec 01 / Zacks.com - Paid Partner Content
Merck (MRK) COVID Pill Less Effective in Final Study, Stock Down
Nov 29 / Zacks.com - Paid Partner Content
Will Moderna Become the Next Big Meme Stock?
Dec 01 / MotleyFool.com - Paid Partner Content
Covid vaccine makers' stocks soar on Omicron variant concerns
Nov 29 / CNN.com
Is This Latecomer a Better Buy Than Moderna and Pfizer?
Dec 01 / MotleyFool.com - Paid Partner Content
Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week
Nov 28 / MotleyFool.com - Paid Partner Content
Exact Sciences Breaks Up With Pfizer -- Time to Buy?
Dec 01 / MotleyFool.com - Paid Partner Content
3 Best Biopharma Stocks to Buy During This Industrywide Fire Sale
Nov 28 / MotleyFool.com - Paid Partner Content
Why Novavax and Pfizer Are Trouncing the Market Today
Nov 30 / MotleyFool.com - Paid Partner Content
2 No-Brainer Buys for 2022
Nov 28 / MotleyFool.com - Paid Partner Content
Nov 30 / GuruFocus News - Paid Partner Content
Got $5,000? These 2 Stocks Could Be Bargain Buys in 2022
Nov 27 / MotleyFool.com - Paid Partner Content
Top Research Reports for Mastercard, Pfizer & Nike
Nov 30 / Zacks.com - Paid Partner Content
4 Reasons Why You Should Add Sarepta (SRPT) to Your Portfolio
Nov 26 / Zacks.com - Paid Partner Content
Caxton Associates Drives Further Into Tesla in the 3rd Quarter
Nov 30 / GuruFocus News - Paid Partner Content
Wall Street Tumbles on Resurgence of Coronavirus
Nov 26 / Zacks.com - Paid Partner Content
Merck's (MRK) Keytruda Gets Europe Nod for Two Carcinomas
Nov 30 / Zacks.com - Paid Partner Content
Black Friday Meets "Black Friday:" New Covid Variant Hits Markets
Nov 26 / Zacks.com - Paid Partner Content